This inventor holds 1 USPTO granted patent. Top assignee: Innogenetics N.v.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Jean-Pierre Draye
Introduction
Jean-Pierre Draye is a notable inventor based in Chaste, Belgium. He has made significant contributions to the field of biopolymers, particularly in the development of medicaments that utilize modified gelatin. His work has implications for medical applications, especially in wound care and controlled drug release.
Latest Patents
Jean-Pierre Draye holds a patent for "Medicaments based on polymers composed of methacrylamide-modified gelatin." This invention relates to a composition that includes a biopolymer matrix made from cross-linked vinyl-derivatives of gelatin or co-polymerized methacrylamide modified gelatin with vinyl-modified polysaccharides. The invention also encompasses a wound dressing or controlled release device that utilizes this biopolymer matrix. The matrix can be formed into various structures, such as hydrated films, foams, fibers, or microbeads, which are designed to maintain optimal humidity for therapeutic purposes.
Career Highlights
Jean-Pierre Draye is associated with Innogenetics N.V., a company known for its innovative approaches in biotechnology. His work at Innogenetics has allowed him to explore the intersection of polymer science and medicine, leading to advancements in patient care.
Collaborations
Throughout his career, Jean-Pierre has collaborated with esteemed colleagues such as Etienne Honore Schacht and An Van Den Bulcke. These collaborations have fostered a rich environment for innovation and have contributed to the success of his projects.
Conclusion
Jean-Pierre Draye's contributions to the field of biopolymers and medicaments highlight the importance of innovation in medical technology. His patent and work at Innogenetics demonstrate a commitment to improving healthcare solutions through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
